Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  50 results for ""Receptor, EphA2""

Your Filters

Subject : breast neoplasms
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

LncRNA LINC00466 Promotes the Progression of Breast Cancer via miR-4731-5p/EPHA2 Pathway.

  • Authors : Han X; Department of Immunology, School of Laboratory Medicine, Bengbu Medical University, Bengbu, 233030, China.; Anhui Provincial Key Laboratory of Infection and Immunity, Bengbu Medical University, Bengbu, 233030, China.

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

  • Source: Current pharmaceutical biotechnology [Curr Pharm Biotechnol] 2025; Vol. 26 (1), pp. 120-131.Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 100960530 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

In vitro analysis of single chain variable fragment-based immunotoxins against Erythropoietin-producing hepatocellular A2 receptor overexpressed in breast cancer cells.

  • Authors : Faraz A; Department of Cellular and Molecular Biology, North Tehran Branch, Islamic Azad University, Tehran, Iran.; Amani J

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/immunology ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/immunology ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism

  • Source: Journal of immunological methods [J Immunol Methods] 2024 Oct; Vol. 533, pp. 113732. Date of Electronic Publication: 2024 Aug 06.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

TYRO3 and EPHA2 Expression Are Dysregulated in Breast Cancer.

  • Authors : de Aguiar ACF; Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil.; Molecular Prospection and Bioinformatics Group, Recife, Pernambuco, Brazil.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

  • Source: Cell biochemistry and function [Cell Biochem Funct] 2024 Sep; Vol. 42 (7), pp. e4128.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium: Internet ISSN: 1099-0844

Record details

Read More Add to Saved list
×
Academic Journal

The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.

  • Authors : Wu Y; Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang 443002, P.R. China.; College of Basic Medical Science, China Three Gorges University, Yichang 443002, P.R. China.

Subjects: Esophageal Neoplasms* ; Esophageal Squamous Cell Carcinoma* ; Breast Neoplasms*

  • Source: Current medicinal chemistry [Curr Med Chem] 2023; Vol. 30 (20), pp. 2340-2353.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen.

  • Authors : Yonehara K; Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama.; Department of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama.

Subjects: Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*pharmacology ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*metabolism ; Receptor, EphA2/Receptor, EphA2/Receptor, EphA2/*metabolism

  • Source: Biological & pharmaceutical bulletin [Biol Pharm Bull] 2022; Vol. 45 (2), pp. 162-168.Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 9311984 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.

  • Authors : Han B; Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Exosomes*/Exosomes*/Exosomes*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

  • Source: Theranostics [Theranostics] 2022 May 13; Vol. 12 (9), pp. 4127-4146. Date of Electronic Publication: 2022 May 13 (Print Publication: 2022).Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

[Overexpression of ephrin-A receptor 2 (EphA2) in invasive breast cancer tissues and its negative correlation with pyroptosis].

  • Authors : Liu K; Department of Urology, Clinical Medical College of Ningxia Medical University, Yinchuan 750004, China.; Wu L

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Pyroptosis*; Receptor, EphA2/Receptor, EphA2/Receptor, EphA2/*genetics

  • Source: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology [Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi] 2021 Nov; Vol. 37 (11), pp. 981-986.Publisher: Xi bao yu fen zi mian yi xue za zhi bian ji bu Country of Publication: China NLM ID: 101139110 Publication Model: Print Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.

  • Authors : Liu Z; Department of Pathology, Municipal People's Hospital, Maanshan, 243000, Anhui, China.; Tao Z

Subjects: Drug Delivery Systems*; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Nanoparticles/Nanoparticles/Nanoparticles/*administration & dosage

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2018 Apr; Vol. 81 (4), pp. 687-695. Date of Electronic Publication: 2018 Feb 01.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

EphA2: A promising therapeutic target in breast cancer.

  • Authors : Zhao P; Department of the First Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650118, China.; Jiang D

Subjects: Molecular Targeted Therapy*; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics ; Carcinogenesis/Carcinogenesis/Carcinogenesis/*genetics

  • Source: Journal of genetics and genomics = Yi chuan xue bao [J Genet Genomics] 2021 Apr 20; Vol. 48 (4), pp. 261-267. Date of Electronic Publication: 2021 Mar 29.Publisher: Science press Country of Publication: China NLM ID: 101304616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.

  • Authors : Gao Z; Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*metabolism ; Ephrin-A1/Ephrin-A1/Ephrin-A1/*metabolism

  • Source: Cell death & disease [Cell Death Dis] 2021 Apr 20; Vol. 12 (5), pp. 414. Date of Electronic Publication: 2021 Apr 20.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  50 results for ""Receptor, EphA2""